ArticleAnnals of the Royal College of Surgeons of England2026
Suprapubic catheter insertion: a multicentre review on mortality during short-, medium- and long-term follow-up.
Article in Annals of the Royal College of Surgeons of England, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe aim of this study was to improve shared and informed decision making regarding real-world mortality rates caused by suprapubic catheter (SPC) insertion.
methodsWe undertook tri-centric, retrospective data collection from all patients identified as having a SPC inserted between 2017 and 2022. Data including demographics, frailty scores, comorbidities, reason for SPC insertion and mortality information were collected and statistically analysed.
resultsSixty-eight patients were identified and included in this study. Mortality after SPC insertion at 30 days was 1.5%: 18.8% at 1 year and 30.4% at 2 years. Medium-term mortality rates were 45.2% at 3 years, rising to 54.5% at 4 years. Patients aged 71 or older at the time of SPC insertion had an overall mortality of 45.9% compared with 10.3% in those aged under 71 years (
conclusionsSPC insertion is associated with a significant mortality rate of 18.8% at 1 year rising to 45.2% at 3 years in our study cohort. Patients with increasing age and frailty may also be at a greater risk of mortality after SPC insertion. This information is in keeping with the limited data available in the published literature and should be highlighted to clinicians and patients when considering SPC insertion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.